Single-nucleotide-specific siRNA targeting in a dominant-negative skin model

Journal of Investigative Dermatology

Volumn 128, Issue 3, 2008, Pages 594-605

  Hickerson, Robyn P ^a   Smith, Frances J D ^b   Reeves, Robert E ^c   Contag, Christopher H ^c   Leake, Devin ^d   Leachman, Sancy A ^e   Milstone, Leonard M ^f   McLean, W H Irwin ^b   Kaspar, Roger L ^a,g  

^a TransDerm Inc   (United States)

^b UNIVERSITY OF DUNDEE   (United Kingdom)

^c STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Thermo Fisher Scientific   (United States)

^e UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FIREFLY LUCIFERASE; NUCLEOTIDE; SMALL INTERFERING RNA;

ARTICLE; CONGENITAL PACHYONYCHIA; CONTROLLED STUDY; EMBRYO; GENE CONSTRUCT; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VIVO STUDY; KNOCKOUT GENE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RNA INTERFERENCE; SKIN; WILD TYPE;

ANIMALS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION; GENE THERAPY; HUMANS; KERATIN-6; KERATINOCYTES; KIDNEY; LIVER NEOPLASMS; MICE; MICE, INBRED STRAINS; PACHYONYCHIA CONGENITA; RNA, SMALL INTERFERING; TRANSFECTION;

EID: 39149111247     PISSN: 0022202X     EISSN: 15231747     Source Type: Journal    
DOI: 10.1038/sj.jid.5701060     Document Type: Article

References (54)

1. Bonifas JM, Rothman AL, Epstein EH Jr (1991) Epidermolysis bullosa simplex: evidence in two families for keratin gene abnormalities. Science 254:1202-5
2. Boukamp P, Petrussevska RT, Breitkreutz D, Hornung J, Markham A, Fusenig NE (1988) Normal keratinization in a spontaneously immortalized aneuploid human keratinocyte cell line. J Cell Biol 106:761-71
3. Braasch DA, Jensen S, Liu Y, Kaur K, Arar K, White MA et al. (2003) RNA interference in mammalian cells by chemically-modified RNA. Biochemistry 42:7967-75
4. Brummelkamp TR, Bernards R, Agami R (2002) Stable suppression of tumorigenicity by virus-mediated RNA interference. Cancer Cell 2: 243-7
5. Cao T, Longley MA, Wang XJ, Roop DR (2001) An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J Cell Biol 152:651-6
6. Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg RJ et al. (2005a) Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80:134-9
7. Cao YA, Bachmann MH, Beilhack A, Yang Y, Tanaka M, Swijnenburg RJ et al. (2005b) Molecular imaging using labeled donor tissues reveals patterns of engraftment, rejection, and survival in transplantation. Transplantation 80:134-9
8. Chiu YL, Rana TM (2003) siRNA function in RNAi: a chemical modification analysis. RNA 9:1034-48
9. Coulombe PA, Hutton ME, Letai A, Hebert A, Paller AS, Fuchs E (1991) Point mutations in human keratin 14 genes of epidermolysis bullosa simplex patients: genetic and functional analyses. Cell 66: 1301-11
10. Czauderna F, Fechtner M, Dames S, Aygun H, Klippel A, Pronk GJ et al. (2003) Structural variations and stabilising modifications of synthetic siRNAs in mammalian cells. Nucleic Acids Res 31:2705-16
11. de Felipe P, Luke GA, Hughes LE, Gani D, Halpin C, Ryan MD (2006) E unum pluribus: multiple proteins from a self-processing polyprotein. Trends Biotechnol 24:68-75
12. Ding H, Schwarz DS, Keene A, Affar el B, Fenton L, Xia X et al. (2003) Selective silencing by RNAi of a dominant allele that causes amyotrophic lateral sclerosis. Aging Cell 2:209-17
13. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D et al. (2001) Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: a putative ribosomal 'skip'. J Gen Virol 82:1013-25
14. Du Q, Thonberg H, Wang J, Wahlestedt C, Liang Z (2005) A systematic analysis of the silencing effects of an active siRNA at all single-nucleotide mismatched target sites. Nucleic Acids Res 33:1671-7
15. Dykxhoorn DM, Lieberman J (2006) Knocking down disease with siRNAs. Cell 126:231-5
16. Dykxhoorn DM, Palliser D, Lieberman J (2006a) The silent treatment: siRNAs as small molecule drugs. Gene Therapy 13:541-52
17. Dykxhoorn DM, Schlehuber LD, London IM, Lieberman J (2006b) Determinants of specific RNA interference-mediated silencing of human betaglobin alleles differing by a single nucleotide polymorphism. Proc Natl Acad Sci USA 103:5953-8
18. Elbashir SM, Martinez J, Patkaniowska A, Lendeckel W, Tuschl T (2001) Functional anatomy of siRNAs for mediating efficient RNAi in Drosophila melanogaster embryo lysate. EMBO J 20:6877-88
19. Giladi H, Ketzinel-Gilad M, Rivkin L, Felig Y, Nussbaum O, Galun E (2003) Small interfering RNA inhibits hepatitis B virus replication in mice. Mol Ther 8:769-76
20. Hengge UR (2006) Gene therapy progress and prospects: the skin - easily accessible, but still far away. Gene Therapy 13:1555-63
21. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC (1995) Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 10:161-6
22. Hengge UR, Walker PS, Vogel JC (1996) Expression of naked DNA in human, pig, and mouse skin. J Clin Invest 97:2911-6
23. Irvine AD, McLean WHI (1999) Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 140:815-28
24. Khavari PA, Rollman O, Vahlquist A (2002) Cutaneous gene transfer for skin and systemic diseases. J Intern Med 252:1-10
25. Lane EB (1993) Keratins. In: Connective tissue and its heritable disorders molecular, genetic and medical aspects (Royce P, Steinmann B, eds), New York: Wiley-Liss Inc, 237-47
26. Lane EB, Rugg EL, Navsaria H, Leigh IM, Heagerty AH, Ishida-Yamamoto A., et al. (1992) A mutation in the conserved helix termination peptide of keratin 5 in hereditary skin blistering. Nature 356:244-6
27. Layzer JM, McCaffrey AP, Tanner AK, Huang Z, Kay MA, Sullenger BA (2004) In vivo activity of nuclease-resistant siRNAs. RNA 10:766-71
28. Leachman SA, Kaspar RL, Fleckman P, Florell SR, Smith FJD, McLean WHI et al. (2005) Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc 10:3-17
29. Lewin AS, Glazer PM, Milstone LM (2005) Gene therapy for autosomal dominant disorders of keratin. J Investig Dermatol Symp Proc 10:47-61
30. Lin MT, Levy ML, Bowden PE, Magro C, Baden L, Baden HP et al. (1999) Identification of sporadic mutations in the helix initiation motif of keratin 6 in two pachyonychia congenita patients: further evidence for a mutational hot spot. Exp Dermatol 8:115-9
31. McCaffrey AP, Nakai H, Pandey K, Huang Z, Salazar FH, Xu H et al. (2003) Inhibition of hepatitis B virus in mice by RNA interference. Nat Biotechnol 21:639-44
32. McLean WHI, Rugg EL, Lunny DP, Morley SM, Lane EB, Swensson O et al. (1995) Keratin 16 and keratin 17 mutations cause pachyonychia congenita. Nat Genet 9:273-8
33. McLean WHI, Smith FJD, Cassidy AJ (2005) Insights into genotype-phenotype correlation in pachyonychia congenita from the human intermediate filament mutation database. J Investig Dermatol Symp Proc 10:31-6
34. Miller VM, Xia H, Marrs GL, Gouvion CM, Lee G, Davidson BL et al. (2003) Allele-specific silencing of dominant disease genes. Proc Natl Acad Sci USA 100:7195-200
35. Morrissey DV, Blanchard K, Shaw L, Jensen K, Lockridge JA, Dickinson B et al. (2005) Activity of stabilized short interfering RNA in a mouse model of hepatitis B virus replication. Hepatology 41:1349-56
36. Omary MB, Coulombe PA, McLean WH (2004) Intermediate filament proteins and their associated diseases. N Engl J Med 351:2087-100
37. Pines M, Domb A, Ohana M, Inbar J, Genina O, Alexiev R et al. (2001) Reduction in dermal fibrosis in the tight-skin (Tsk) mouse after local application of halofuginone. Biochem Pharmacol 62:1221-7
38. Prud'homme GJ, Glinka Y, Khan AS, Draghia-Akli R (2006) Electroporation-enhanced nonviral gene transfer for the prevention or treatment of immunological, endocrine and neoplastic diseases. Curr Gene Ther 6:243-73
39. Sawamura D, Akiyama M, Shimizu H (2002) Direct injection of naked DNA and cytokine transgene expression: implications for keratinocyte gene therapy. Clin Exp Dermatol 27:480-4
40. Schwarz DS, Ding H, Kennington L, Moore JT, Schelter J, Burchard J et al. (2006) Designing siRNA that distinguish between genes that differ by a single nucleotide. PLoS Genet 2:e140
41. Shaner NC, Campbell RE, Steinbach PA, Giepmans BN, Palmer AE, Tsien RY (2004) Improved monomeric red, orange and yellow fluorescent proteins derived from Discosoma sp. red fluorescent protein. Nat Biotechnol 22:1567-72
42. Shaner NC, Steinbach PA, Tsien RY (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905-9
43. Smith F (2003) The molecular genetics of keratin disorders. Am J Clin Dermatol 4:347-64
44. Smith FJD, Kaspar RL, Schwartz ME, McLean WHI, Leachman SA (2006) Pachyonychia congenita. GeneReviews; www.genetests.org/profiles/pc
45. Smith FJD, Liao H, Cassidy AJ, Stewart A, Hamill KJ, Wood P et al. (2005) The genetic basis of pachyonychia congenita. J Investig Dermatol Symp Proc 10:21-30
46. Smith FJD, McKenna KE, Irvine AD, Bingham EA, Coleman CM, Uitto J et al. (1999) A mutation detection strategy for the human keratin 6A gene and novel missense mutations in two cases of pachyonychia congenita type 1. Exp Dermatol 8:109-14
47. Song E, Lee SK, Wang J, Ince N, Ouyang N, Min J et al. (2003) RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med 9:347-51
48. Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. (2004) Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 432:173-8
49. Steinert PM, Yang JM, Bale SJ, Compton JG (1993) Concurrence between the molecular overlap regions in keratin intermediate filaments and the locations of keratin mutations in genodermatoses. Biochem Biophyl Res Commun 197:840-8
50. Wang Q, Contag CH, Ilves H, Johnston BH, Kaspar RL (2005) Small hairpin RNAs efficiently inhibit hepatitis C IRES-mediated gene expression in human tissue culture cells and a mouse model. Mol Ther 12: 562-8
51. Wang Q, Ilves H, Chu P, Contag CH, Leake D, Johnston BH et al. (2007) Delivery and inhibition of reporter genes by small interfering RNAs in a mouse skin model. J Invest Dermatol doi:10.1038/sj.jid.5700891
52. Wesche-Soldato DE, Chung CS, Lomas-Neira J, Doughty LA, Gregory SH, Ayala A (2005) In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood 106:2295-301
53. Woll S, Windoffer R, Leube RE (2005) Dissection of keratin dynamics: different contributions of the actin and microtubule systems. Eur J Cell Biol 84:311-28
54. Wong P, Domergue R, Coulombe PA (2005) Overcoming functional redundancy to elicit pachyonychia congenita-like nail lesions in transgenic mice. Mol Cell Biol 25:197-205